SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theravance - THRX -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (37)8/27/2006 10:50:51 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 74
 
That wouldn't make any sense to me - that's not a two-bites at the cherry situation.

Strictly speaking this is two bites at the apple because a trial could hit either non-inferiority or superiority without hitting the other. In practice, hitting on superiority while missing on non-inferiority is rare, but it can happen.

A protocol where the aggregate 0.05 of p-value in split in half for each endpoint is fairly common.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News